Here are four observations:
1. The implants are knee prosthesis components for orthopedic surgery.
2. DePuy Orthopaedics is recalling the implants because they have higher rates of revision in Australia when the native patella is not resurfaced when compared to other unresurfaced PS implants.
3. If the system is implanted and the native patella is not resurfaced, the patient may experience patello-femoral pain, and may potentially require a secondary procedure.
4. The system has been distributed in countries worldwide, including China, Belgium, France, Australia and South Africa.
More articles on devices:
Boston Scientific launches Precision Novi SCS in Europe — 5 key notes
Zimmer, Centinel Spine, Mazor Robotics & more — 14 key notes
BioMedical Enterprises launches nitinol bone fixation implant: 5 things to know
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
